Inquiry Basket
Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist. It decreases tumor volume of Dunning R3327H prostate tumor flank implants in rats when administered at a dose of 1 mg/kg per month. Formulations containing degarelix have been used in the treatment of advanced prostate cancer.
Size | Price | Stock | Quantity |
---|---|---|---|
250 mg | $1099 | In stock |